drugset / Trial / NCT07486115
A Study to Test How Different Doses of BI 3814916 Are Tolerated by Healthy People
RandomizedParallel-groupSingle-blindTreatment
Summary
The main objectives of this trial are to investigate safety, tolerability and pharmacokinetics (PK) of BI 3814916 in healthy male and female trial participants.
Timeline
- Start
- 2026-05-20
- Primary completion
- 2027-07-12
- Completion
- 2027-07-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 3814916 | Unknown | — | — |
Indications
No indication recorded.